ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1892

High-Throughput Immunoglobulin G Fab Glycosylation Profiling Reveals Differential Glycosylation On Fab and Fc

Albert Bondt1,2, Yoann Rombouts3, Maurice H.J. Selman1, Radboud JEM Dolhain4 and Manfred Wuhrer1, 1Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Erasmus University Medical Center, Rotterdam, Netherlands, 3Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 4Rheumatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: glycoproteins, Immunoglobulin (IG), pregnancy and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics and Genomics of Rheumatic Disease II

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Rheumatoid arthritis is known to improve during pregnancy, and a flare of disease activity is observed after delivery (1). N-glycosylation of the constant region (Fc) of immunoglobulin (Ig) G has been associated with these observations (2). However, glycosylation of the antigen binding fragment (Fab) of IgG might also play a role. Fab glycosylation has been suggested to influence affinity to antigen, and antibody half-life (3, 4). Analysis of Fab glycosylation is challenging because of the hypervariable properties of IgG Fab. Here we describe a newly developed highly specific method for the analysis of Fab N-glycosylation.

  Methods:

Sera were collected three times during pregnancy and three times after delivery from healthy individuals participating in a prospective cohort study on Pregnancy induced Amelioration of Rheumatoid Arthritis (PARA-study). IgG was affinity purified from the sera using IgG-Fc (Hu) beads. Using FabRICATOR® enzyme IgG was cleaved in two ½ Fc portions and a F(ab’)2 portion. Fc and F(ab’)2 were separated, and glycans were released followed by automated MALDI-TOF measurement to establish the levels as well as patterns of glycosylation.

  Results:

In healthy pregnant individuals Fc and Fab show distinct glycosylation patterns (Figure 1). Levels of galactosylation and sialylation are higher on Fab compared to Fc (±94% vs. ±60% and ±60% vs. ±15%, respectively). However, while major changes occur in these features on IgG Fc during pregnancy, the levels appear to be stable at the Fab portion. On the other hand, fucosylation and bisecting N-acetylglucosamine do not change drastically on the Fc portion with pregnancy, while pronounced lowered levels of both glycosylation features are observed during pregnancy in these individuals.

  Conclusion:

Data obtained from serum of healthy pregnant individuals reveals differential glycosylation on Fab compared to Fc. Fab and Fc were found to show distinct glycosylation changes with pregnancy. In the near future we will apply this method to RA patient sera to identify whether Fc or Fab glycosylation could be a bigger effector in the improvement of RA during pregnancy.

Figure 1 Typical IgG Fab (A) and Fc (B) spectra showing distinguishable AA-labeled glycans

 

Acknowledgements

This research project is financed by the Dutch Arthritis Foundation.

 

References

1.         de Man YA, Dolhain RJEM, van de Geijn FE, Willemsen SP, Hazes JMW. Arthritis Rheum 2008;59:1241-8.

2.         van de Geijn FE, Wuhrer M, Selman MH, Willemsen SP, de Man YA, Deelder AM, et al. Arthritis Res Ther 2009;11:R193.

3.         Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. Annu Rev Immunol 2007;25:21-50.

4.         Huang L, Biolsi S, Bales KR, Kuchibhotla U. Anal Biochem 2006;349:197-207.

 


Disclosure:

A. Bondt,
None;

Y. Rombouts,
None;

M. H. J. Selman,
None;

R. J. Dolhain,
None;

M. Wuhrer,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-throughput-immunoglobulin-g-fab-glycosylation-profiling-reveals-differential-glycosylation-on-fab-and-fc/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology